{"nct_id":"NCT05733611","title":"RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-01","start_date":"2023-06-29","start_date_type":"ACTUAL","primary_completion_date":"2027-01-01","primary_completion_date_type":"ESTIMATED","completion_date":"2027-03-01","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["REPL"]}